Evidence map›Paper›PMID 39699425›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2024

Long-term chronic infection of a young immunocompromised patient by the SARS-CoV-2 P.2 VOI.

Camila Malta Romano, Vitor Gabriel Lopes da Silva, Luciane Sussuchi da Silva, Carolina Sanchez Aranda, Cristina Mendes de Oliveira, Marilda Mendonça Teixeira Siqueira, Elisa Cavalcante Pereira, Paola Cristina Resende, Nancy Cristina Junqueira Bellei, José Eduardo Levi and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camila Malta RomanoUniversidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de São Paulo, Laboratório de Virologia (LIM-52), São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-4550-1987
Vitor Gabriel Lopes da SilvaUniversidade Federal de São Paulo, Departamento de Pediatria, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-8802-8117
Luciane Sussuchi da SilvaDasa, São Paulo, São Paulo, Brazil.
Carolina Sanchez ArandaUniversidade Federal de São Paulo, Departamento de Pediatria, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-2187-8192
Cristina Mendes de OliveiraDasa, São Paulo, São Paulo, Brazil.
Marilda Mendonça Teixeira SiqueiraFiocruz, Instituto Oswaldo Cruz, Laboratório de Virus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, Rio de Janeiro, Brazil.
Elisa Cavalcante PereiraFiocruz, Instituto Oswaldo Cruz, Laboratório de Virus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, Rio de Janeiro, Brazil.
Paola Cristina ResendeFiocruz, Instituto Oswaldo Cruz, Laboratório de Virus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Rio de Janeiro, Rio de Janeiro, Brazil.
Nancy Cristina Junqueira BelleiUniversidade Federal de São Paulo, Laboratório de Virologia Clínica, São Paulo, São Paulo, Brazil.
José Eduardo LeviUniversidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de São Paulo, Laboratório de Virologia (LIM-52), São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-3557-2717
Maria Isabel de Moraes-PintoUniversidade Federal de São Paulo, Departamento de Pediatria, São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-7345-5477

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An immunocompromised patient was infected by the SARS-CoV-2 variant of interest named Zeta (P.2) in February 2021. More than one year later, he suffered from symptomatic COVID-19 and sequencing revealed the same variant, which accumulated 23 substitutions. This case illustrates intra-host evolution of a particular SARS-CoV-2 variant, highlighting the importance of genomic surveillance of immunocompromised patients.

Indexed as

COVID-19Immunocompromised HostSARS-CoV-2AdolescentChronic DiseaseHumansMale

Identifiers

PMID39699425
PMCPMC11654138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.